H1 vs. TriNetX
TriNetX shows you a keyhole. H1 opens the door to thousands of research-ready sites worldwide, delivering the comprehensive data you need for smarter, faster, and more representative clinical trials.
Trusted by 250+ leading companies
Trusted by industry leaders
The Measurable Difference with H1
higher patient coverage in H1 data compared to TriNetX, based on 3 in 4 disease states analyzed
more patient coverage in key oncology cancers compared to TriNetX
more patient coverage in certain disease states compared to TriNetX
H1’s Site Coverage Far Exceeds What TriNetX Offers
TriNetX only shows you the top major hospitals and health systems. H1 gives you access to thousands of global research-ready community hospitals, specialty practices and clinics in addition to hospitals and health systems so you can select the optimal sites for your global trials.
TriNetX offers limited global coverage—H1 doesn’t stop at borders. Access detailed profiles on thousands of principal investigators across the globe with insights into their specialties, trial history, proven performance, and more.
If you’re looking to design trials that represent actual patient populations, TriNetX is missing key insights. H1 provides critical data on demographics and SDOH factors, helping you identify sites and investigators who can reach underrepresented populations.
While others are still figuring out AI, H1 is leading in advanced generative capabilities that transform site selection and clinical operations. Our AI-powered platform enables you to make confident, data-driven decisions in a fraction of the time.
H1’s Site Coverage Far Exceeds What TriNetX Offers
TriNetX only shows you the top major hospitals and health systems. H1 gives you access to thousands of global research-ready community hospitals, specialty practices and clinics in addition to hospitals and health systems so you can select the optimal sites for your global trials.
TriNetX offers limited global coverage—H1 doesn’t stop at borders. Access detailed profiles on thousands of principal investigators across the globe with insights into their specialties, trial history, proven performance, and more.
If you’re looking to design trials that represent actual patient populations, TriNetX is missing key insights. H1 provides critical data on demographics and SDOH factors, helping you identify sites and investigators who can reach underrepresented populations.
While others are still figuring out AI, H1 is leading in advanced generative capabilities that transform site selection and clinical operations. Our AI-powered platform enables you to make confident, data-driven decisions in a fraction of the time.
“TriNetX doesn’t provide enough context around which HCPs and sites are best to work with per country from a clinical trial perspective.”
Former TriNetX user, current H1 client
BioMarin Decreases Time Spent on Vetting Sites with H1
“Because of the advances in technology platforms, H1 being one of them, we are able to decrease the time it takes for the initial vetting of our sites, and this has proven to be an efficiency gain for us in the clinical operations world.”
– Pamela Fearon, VP, Global Study Operations at BioMarin
H1 offers tens of thousands of sites globally, whereas TrinetX is only focused on the top health systems. You don’t need a database subscription to tell you that MSK has cancer patients, but finding the community care is where H1 makes the difference.
H1 aggregates data from verified public and proprietary sources and continuously updates it to ensure accuracy and relevance for clinical trial planning.
H1 has a more robust generative AI roadmap, offering advanced features to enhance competitive intelligence and data-driven decision-making. These AI-powered search and filtering tools help you quickly surface the most relevant insights, reducing manual effort and accelerating results.